Global Diphtheria, Pertussis, and Tetanus (DTaP) Vaccine Market is Expected to Reach USD 5.07 Billion by 2026 : Fior Markets

NEXT STORY
I-MAB Announces Pricing of U.S. Initial Public Offering
PREV STORY
Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes and established CVD
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Delcath Announces First Quarter 2018 Financial Results

NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional ...

author_avatar
NASDAQ Market News

Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in May and June

Press Release 14 May 2018 Immunicum AB (publ) Announces Upcoming Presentations and Attendances at ...

author_avatar
NASDAQ Market News

Recro Pharma Announces Publication of Phase III IV Meloxicam Abdominoplasty Data in Plastic and Reconstructive Surgery Global Open Journal

MALVERN, Pa., June 26, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue ...

author_avatar
NASDAQ Market News